Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
Date
2023-12
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
RECOVERY Collaborative Group & Cooper, J 2023, 'Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial', The lancet. Diabetes & endocrinology, vol. 11, no. 12, pp. 905-914. https://doi.org/10.1016/S2213-8587(23)00253-X